This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: National Institute of Health and Medical Research. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Abdoulaye Sene: Innovator in Angiogenesis Modulation
Introduction
Abdoulaye Sene is a prominent inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the modulation of angiogenesis. His innovative work has the potential to impact therapeutic approaches for various medical conditions.
Latest Patents
Abdoulaye Sene holds a patent titled "Methods for modulating angiogenesis via dystrophin Dp71." This invention relates to methods and compositions for inhibiting or stimulating angiogenesis. The invention highlights the role of Dp71 in angiogenesis, providing novel therapeutic approaches and methods for screening agents that modulate angiogenesis targeting this protein. Specifically, the patent discusses the use of Dp71 or its variants for stimulating angiogenesis in subjects, particularly humans, and the use of Dp71 inhibitors for inhibiting angiogenesis.
Career Highlights
Abdoulaye Sene is affiliated with the Institut National de la Santé et de la Recherche Médicale, where he conducts his research. His work has garnered attention for its innovative approach to understanding and manipulating angiogenesis, which is crucial for various physiological and pathological processes.
Collaborations
Abdoulaye has collaborated with notable colleagues, including Romain Bernard and Bénédicte Dupas. These collaborations have further enriched his research and contributed to advancements in the field.
Conclusion
Abdoulaye Sene's contributions to the field of angiogenesis modulation through his patent and research at the Institut National de la Santé et de la Recherche Médicale underscore his role as an influential inventor. His work holds promise for developing new therapeutic strategies in medicine.